mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0075 |
0.8 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.8 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.8 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.8 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.8 |